Your browser doesn't support javascript.
loading
Clinical performance evaluation of BD SARS-CoV-2 reagents for BD MAXTM System in asymptomatic individuals.
Yanson, Karen; Laviers, William; Suhaidi, Faten; Greeley, Zachary; Merryman, Courtney; Proctor, Reda; Hall, Dominique; Neely, Lori.
Afiliación
  • Yanson K; Becton, Dickinson and Company, BD Life Sciences - Integrated Diagnostic Solutions, Sparks, MD, USA. Electronic address: Karen_Yanson@bd.com.
  • Laviers W; Becton, Dickinson and Company, BD Life Sciences - Integrated Diagnostic Solutions, Sparks, MD, USA.
  • Suhaidi F; Becton, Dickinson and Company, BD Life Sciences - Integrated Diagnostic Solutions, Sparks, MD, USA.
  • Greeley Z; Becton, Dickinson and Company, BD Life Sciences - Integrated Diagnostic Solutions, Sparks, MD, USA.
  • Merryman C; Becton, Dickinson and Company, BD Life Sciences - Integrated Diagnostic Solutions, Sparks, MD, USA.
  • Proctor R; Becton, Dickinson and Company, BD Life Sciences - Integrated Diagnostic Solutions, Sparks, MD, USA.
  • Hall D; Becton, Dickinson and Company, BD Life Sciences - Integrated Diagnostic Solutions, Sparks, MD, USA.
  • Neely L; Becton, Dickinson and Company, BD Life Sciences - Integrated Diagnostic Solutions, Sparks, MD, USA. Electronic address: Lori.Neely@BD.com.
Diagn Microbiol Infect Dis ; 105(2): 115861, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36495738

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Diagn Microbiol Infect Dis Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Diagn Microbiol Infect Dis Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos